Selected References:
- Cazzola M, et al. 2002. Clinical pharmacokinetics of salmeterol. Clin Pharmacokinet, 41(1):19-30.
- Cossette B, et al. 2014. Relative perinatal safety of salmeterol vs formoterol and fluticasone vs budesonide use during pregnancy. Ann Allergy Asthma Immunol, 112(5):459-464.
- GlaxoSmithKline LLC. 2020. Serevent diskus prescribing information.
- Jones KL, et al. 2002. Salmeterol use and pregnancy outcomes: a prospective multi-center study. J Allergy Clin Immunol, 109:S156.
- Lim A, et al. 2011 Systematic review of the safety of regular preventive asthma medications during pregnancy. Ann Pharmacother, 5(7-8):931-945.
- National Asthma Education and Prevention Program Asthma and Pregnancy Working Group. 2025. NAEPP expert panel report: managing asthma during pregnancy—recommendations for pharmacologic treatment—2004 update. J Allergy Clin Immunol, 115(1):34–46.
- Taddio A, Ito S. 2001. Drugs and breast-feeding. In: Koren G, ed. Maternal-fetal toxicology. A clinician’s guide. 3rd ed. New York: Marcel Dekker, 177-132.
- Wilton LV, et al. 1998. The outcomes of pregnancy in women exposed to newly marketed drugs in general practice in England. Br J Obstet Gynaecol, 105:882-889.
